SCHEMBL69496

SCHEMBL69496

CCOC(=O)C1(C(=O)OCC)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
POLB P06746 1/20 0.42
ALOX15 P16050 2/20 0.42
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
SOAT1 P35610 1/20 0.42
OPRM1 P35372 6/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ATM Q13315 1/20 0.40
OPRD1 P41143 3/20 0.40
OPRK1 P41145 3/20 0.40
SLC22A1 O15245 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
KCNH2 Q12809 1/20 0.40
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18134201 1.00 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL15797775 0.91 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL16089710 0.91 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL28806630 0.91 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL1152835 0.90 SMN1; SMN2 (0.42) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL713102 0.90 SMN1; SMN2 (0.46) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL15362877 0.89 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL17230366 0.89 MEN1 (0.37) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL28039254 0.89 ALOX15 (0.39) ALDH1A1LMNAHSD17B10POLBALOX15
SCHEMBL373936 0.88 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10POLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 489 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117645581-A Method for synthesizing series of functional groups of photocatalytic inert C (sp 3) -H bond 浙江工业大学台州研究院 2024-03-05 CN claimed
CN-115572355-A Water-reducing slump-retaining water reducer and preparation method thereof 中铁十一局集团有限公司 2023-01-06 CN claimed
CN-109311907-A Preparation method of high-purity prasugrel 吉瑞工厂 2019-02-05 CN claimed
CN-106316845-A Preparing method of cis, trans-ethyl 2, 2-dimethyl-3-(1-isobutenyl)cyclopropane-1-carboxylate 江苏优普生物化学科技股份有限公司 2017-01-11 CN claimed
CN-106121365-A A kind of Multifunctional household intelligent safety lock and method of work thereof 王公民 2016-11-16 CN claimed
CN-105385202-A Waterproof agent for swimming pool YANTAI SHUNLONG CHEMICAL TECH CO LTD 2016-03-09 CN claimed
CN-105219536-A A kind of nickel contamination waste material of buildings washing composition YANTAI SHUNLONG CHEMICAL TECHNOLOGY CO LTD 2016-01-06 CN claimed
US-20250353851-A1 PURINES AND METHODS OF THEIR USE KINETA INC (US) 2025-11-20 US disclosed
US-12466821-B2 Antiviral pyridopyrazinedione compounds NOVARTIS AG (CH) 2025-11-11 US disclosed
EP-3745105-B1 TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME HITACHI LTD (JP) 2025-08-27 EP disclosed
CN-119613408-A Bicyclic ketone compounds and methods of use thereof 豪夫迈·罗氏有限公司 2025-03-14 CN disclosed
US-20250074866-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2025-03-06 US disclosed
WO-2025028075-A1 TWO-PACK TYPE RESIN COMPOSITION 株式会社日本触媒 2025-02-06 WO disclosed
EP-0207420-A2 Pyridonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1987-01-07 EP disclosed
US-4431727-A BLEND OF CELLULOSE NITRATE AND HYDROPHOBIC POLYMER; SOLVENT RESISTANCE; MOTION PICTURE FILMS EASTMAN KODAK COMPANY (US) 1984-02-14 US disclosed
EP-0097037-A2 Radiation-sensitive photographic element having a protective overcoat layer EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1983-12-28 EP disclosed
EP-0060077-A1 Beta-lactam antibiotics, their preparation and use BEECHAM GROUP PLC (GB) 1982-09-15 EP disclosed
US-4322541-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1982-03-30 US disclosed
US-4266065-A HYPOTENSIVE ACTIVITY E. R. SQUIBB & SONS, INC. (US) 1981-05-05 US disclosed
US-3935222-A CNS DEPRESSANT, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12466821-B2 Antiviral pyridopyrazinedione compounds ZC3HAV1, IL5, TYMP ALDH1A1 1714/4885LMNA 2847/4885HSD17B10 1400/4885
US-20250074866-A1 MODIFIED AMINE LIPIDS PHOSPHO1, SGMS1, SGMS2 ALDH1A1 1817/4885LMNA 1381/4885HSD17B10 2948/4885
US-20250353851-A1 PURINES AND METHODS OF THEIR USE TDP1, TDP2, PIKFYVE ALDH1A1 4617/4885LMNA 951/4885HSD17B10 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.